2026 Appendix 4E and Annual Report
Filed with ASX · · 88 pages · English
Mayne Pharma Group Ltd. on 6ix
Earlier from Mayne Pharma
- 2026 Full Year Results Investor Presentation
- 2026 Corporate Governance Statement and Appendix 4G
- Notification of date for release of FY26 results
- Upcoming presentation of Imvexxy clinical data
- Mayne Pharma launches Investor Hub
Later from Mayne Pharma
- 2026 Full Year Results Media Release
- Application for quotation of securities - MYX
- Notification regarding unquoted securities - MYX
- Notification of cessation of securities - MYX
- MYX signs licence agreement for Blissel in Australia
Follow Mayne Pharma into a list and get an email when it puts out news.
Follow Mayne Pharma